Transcript Highlights:

• We responded to 1,400 audits, which comprised 2,900 prescriptions.
• They see $2,802.40 for the prescription.
• Are you saying that you lose $30 or $40 per prescription?
• Prescription drugs, two prescription drugs that the FDA has approved that are very expensive.
• have any prescription coverage that's part D right now.

Bills: HB1464, HB1635, HB2516, HB3317, HB3502, HB4012, HB4268, HB4386, HB4877, SB916

Keywords: prescription drugs, drug pricing, pharmacy benefits, health insurance, health benefit plan, insurer, HMO, self-insured employer, public employer, school district, county, municipality, university system, higher education, retirees, dependent coverage, stop-loss coverage, bulk purchasing, group purchasing, purchasing pool

Transcript Highlights:

• In 2024, of the more than 4,000 prescriptions filled by Lānaʻi Community Health Center, 1,781 prescriptions
• > about 1781 prescriptions or about 1781 prescriptions or about onethird<00:37:32.960> were
• the total savings per prescription again the total savings per prescription was $210<00:38:45.200>
• pharmacy but when when your prescription pharmacy but when when your prescription doesn't<00:54:
• <01:10:08.840> to<01:10:09.000> go allow your prescription to go allow your prescription

Keywords: 910, house, all

Summary: The committee heard several measures, beginning with SB 1046 SD1 on condominiums. Testimony on that bill focused on reserve funding and enforcement of reserve study requirements. The Community Associations Institute opposed the bill, saying it would create hardship, confusion, and be difficult to administer, while also urging stronger penalties for boards that fail to comply with reserve study rules. The Real Estate Commission offered comments, and one testifier spoke in support. No vote was taken during the portion provided. The committee then heard SB 532 SD2 HD1 relating to the Department of Education, which would improve access to pre-approved medications for students with health conditions at school and during off-campus activities. The Department of Health, University of Hawaiʻi nursing and medical programs, and the Department of Education all supported the measure, with DOH suggesting amendments to better identify the correct student and improve medication safety. Members had no questions, and the bill moved on. Next was SB 1245 SD2 HD1 relating to pharmacists, a bill to allow reimbursement for clinical services pharmacists are already trained and licensed to provide. The University of Hawaiʻi, Board of Pharmacy, Walgreens, Mikai Drugs, and the Hawaiʻi Pharmacists Association supported the bill, emphasizing improved access to care, recruitment and retention of pharmacists, and better chronic disease management. The Hawaiʻi Pharmacists Association also discussed proposed amendments to prevent plans from denying coverage or network participation when pharmacists meet credentialing requirements. Members questioned whether insurers would actually use pharmacists and how the bill would affect pay and contracting; no vote was taken in the excerpt. The committee also heard SB 1279 SD2 HD1, another pharmacists bill focused on telepharmacy and 340B-related issues. The Department of Corrections and Rehabilitation supported it, saying telehealth could reduce costs and avoid travel for audits, while the Board of Pharmacy opposed it. Lānaʻi representatives opposed the bill and asked for an exemption, arguing the island already has close in-person access to a resident pharmacist and clinics. The Hawaiʻi Primary Care Association supported the measure, citing large patient savings from 340B pricing, while Mikai Drugs opposed it, arguing that mail-order and telepharmacy are not necessary on some islands and can create delivery and medication-safety problems. Members asked questions about insurer participation, scope of practice, and whether the bill would meaningfully change reimbursement; the transcript ends before any final action or vote.

Transcript Highlights:

• purchase outpatient prescription purchase outpatient prescription medications<00:07:12.919> at
• <00:10:34.640> and their ability to fill prescriptions and their ability to fill prescriptions
• We've written almost 5,000 prescriptions in fiscal 2024 at...
• We've written almost 5,000 prescriptions in fiscal 2024 at...
• have provided over 4,500 prescriptions have provided over 4,500 prescriptions to<00:21:16.919>

Keywords: 00:00 Introductions 02:46 Roll Call 03:35 Discussion on SB 14 46:13 Vote on SB 14 48:07 Discussion on SB 17 50:38 Vote on SB 17, 958, all

Summary: The Senate Standing Committee on Health Services opened with the chair welcoming several new members and outlining session rules: hearings would start and end on time, the committee would limit the number of bills heard each meeting, prioritize bills heard during the interim, and generally avoid using the consent calendar except in extreme circumstances. The committee then briefly considered administrative regulations, which were treated as approved if members had no questions. The main item was Senate Bill 14, a measure addressing the 340B drug discount program. The chair said the bill had already passed the Senate in a prior session and had been heard in interim, so he did not present it again. He described the bill as prohibiting drug manufacturers from discriminating against 340B covered entities by refusing 340B pricing when the same drug is offered at that price in the state. He also said the committee would not debate the federal 340B program itself, but would hear testimony on the bill. Hospital leaders and Kentucky Hospital Association representatives testified in support, arguing that 340B savings are essential to rural hospitals, oncology services, transportation support, chronic care, addiction recovery, and new service lines such as chemotherapy and hepatitis treatment. They said the program helps keep care close to home and that manufacturer restrictions on contract pharmacies have reduced access and cost hospitals millions. Opponents from BIO Kentucky and the National Alliance of Healthcare Purchaser Coalitions argued the bill would expand federal law beyond Congress’s intent, create administrative burdens, and not lower patient out-of-pocket costs. The chair repeatedly pressed opponents to address why Kentucky should be denied the same 340B pricing available in other states. No vote on the bill was taken in the portion provided.

Transcript Highlights:

• For example, the board has not verified whether pharmacists reviewed patient prescription use information
• in the database before dispensing controlled substance prescriptions.
• Found that these prescribers collectively issued more than 15,000 prescriptions without checking the
• We're hoping that House Bill 2434, the controlled substance prescription monitoring program bill, will
• I know she's only been on the job for a really short time period.

Keywords: 1182, all

Summary: The committee conducted sunset reviews for the Arizona State Board of Pharmacy, the State Board of Nursing, the Arizona Board of Occupational Therapy Examiners, and the Arizona Regulatory Board of Physician Assistants. The Auditor General’s reports praised each board for timely licensing in some areas but identified recurring problems with complaint investigations, public safety oversight, fee analysis, records/documentation, and internal controls. For Pharmacy, the main concerns were weak enforcement of controlled substances prescription monitoring program (CSPMP) requirements and slow complaint resolution; the board said it had implemented some recommendations, was pursuing a new database vendor, and supported legislation to strengthen CSPMP enforcement. For Nursing, the audit found a large and growing backlog of complaints and repeated delays in resolving cases; the executive director said the board was under-resourced and requested 28 additional investigative positions, while nursing stakeholders supported process reforms and cited a bill to improve timelines and fairness. For Occupational Therapy, the audit focused on missing or poorly documented fingerprint clearance card checks, delayed action on a serious criminal-charge disclosure, and other compliance issues; the board said it had accepted and was implementing all recommendations, including new procedures and rulemaking. For Physician Assistants, the audit found weak oversight by the executive director, extensive delays in complaint handling, and an incentive-pay system that did not align with key performance goals; the board said it had already made structural changes, was improving tracking and IT systems, and planned to continue implementing recommendations. After discussion and testimony from board officials, public members, and nursing stakeholders, the committee voted to continue the Arizona State Board of Pharmacy for six years until July 1, 2032, the State Board of Nursing for four years until July 1, 2031, the Arizona Board of Occupational Therapy Examiners for four years until July 1, 2030, and the Arizona Regulatory Board of Physician Assistants for a continued term with statutory changes (the transcript includes the board review and related discussion, but the final motion text for the physician assistants board is not fully captured in the excerpt). The votes on the first three continuations were approved by roll call, with members generally supporting continuation while expressing concern about complaint backlogs and the need for reforms.

Transcript Highlights:

• It fails to cover the cost of prescriptions plus the cost to dispense them.
• <00:48:56.359> access preserve prescription access preserve prescription access and<00:48:
• But we do so much more than fill patients' prescriptions.
• That's 65% of my prescription business.
• claims that's 65% of my prescription claims that's 65% of my prescription business<00:54:48.599>

Keywords: 1183, house

Transcript Highlights:

• unborn child is less than 20 weeks, or the unborn child weighs less than 350 grams if the gestation period
• And I think that's where the... ...board complaint about multiple prescriptions, right?
• I am confident that we, with time, will be able to eliminate prescription caps altogether.
• I would approve a prescription for a preventative medicine.
• Chestnut: I would approve a prescription for a preventative medicine.

Bills: SB1176, SB1186, SB1235, SB1286, SB1446, SB1458, SB1515, SB1616, SB1641, SB1668, SB1670, SB1678, SB1747, SB1787

Keywords: stormwater, water storage, replenishment credits, groundwater, aquifer, Arizona Revised Statutes, disclosure, state contracts, procurement records, donations, transparency, EMS, reciprocity, interstate compact, paramedics, emergency medical technicians, licensure, public safety, military personnel, veterinary telemedicine

Summary: The committee approved the minutes and then heard Senate Bill 1668, which would extend the deadline for funeral establishments or responsible persons to submit required documentation from seven calendar days to 14 business days and make related changes involving disposition of unborn or stillborn children, minors, and abortion clinic forms. Funeral industry testimony said the current timelines are difficult to meet and create stress for grieving families, while a mother described problems caused by requiring an ex-spouse’s signature after her child’s death. The bill passed on a 4-3 vote, with some members supporting the timing and family-law fixes and others objecting to the abortion-clinic provisions. The committee then took up Senate Bill 1286, on veterinary telemedicine prescriptions. An amendment shortened the telemedicine prescription period for non-antimicrobial drugs from 60 days to 30 days, allowed antimicrobial prescriptions for up to 14 days based on an electronic exam, and barred further antimicrobial prescriptions without an in-person exam. Veterinarians and the Arizona Veterinary Medical Association moved to neutral on the amended bill but warned about safety, overprescribing, and the limits of telemedicine; supporters argued it would improve access for rural, elderly, and low-income pet owners. The committee adopted the amendment and then passed the bill as amended on a 4-3 vote. Senate Bill 1235, creating the emergency services personnel licensure interstate compact, passed unanimously after sponsor testimony that it would improve reciprocity for EMTs and paramedics and help military personnel. Senate Bill 1446, which would change dialysis-center social worker documentation from monthly to quarterly, also passed unanimously, with DeVita Dialysis Services saying the change would reduce paperwork and align Arizona with federal and most-state practice. Senate Bill 1515, a cleanup bill for the Industrial Commission of Arizona that renames positions, removes outdated duties, and changes publication of fee schedules, passed after an amendment and supportive agency testimony. The committee also heard Senate Bill 1678, which would require direct-care staff in certain facilities to complete patient information forms and reestablish the Vulnerable Adult Systems Study Committee. An amendment removed the form requirement and instead required DHS to investigate complaints from EMS personnel about missing DNR orders; first responders and provider groups supported the revised approach, though some members wanted minority-party appointments added to the study committee. The bill passed as amended on a 6-0-1 vote. Finally, the committee began hearing Senate Bill 1747 on social media protections for minors, with the sponsor framing it as a child-safety measure and opponents from NetChoice, TechNet, and Meta warning about privacy risks, age-verification problems, constitutional concerns, and the possibility that teens would evade restrictions; supporters argued parents need stronger controls and pointed to app-store-based alternatives, but no vote was taken in the portion provided.

Transcript Highlights:

• Prescription drugs are life-changing and often life-saving.
• <00:41:28.440> is prescription is prescription is for<00:41:31.000> senat<00:41:31.319>
• :11.000> prescription<00:49:11.520> drugs<00:49:12.079> currently agree that prescription
• Today, about 90% of all prescription drugs dispensed are generic drugs.
• About 90% of all prescription drugs dispensed are generic drugs.

Keywords: 1187, senate, all

Transcript Highlights:

• its doctors and physician assistants to have such actions removed from their online system after a period
• The bill clarifies that pharmacies can deliver prescription medications.
• That is, a lot of different prescription drugs could be taken here, you know, that we don't have any
• Madam Chair, Representative Contreras, that is our concern: without language clarifying what prescription
• Madam Chair, Representative Contreras, that is our concern: without language clarifying what prescription

Bills: HB2408, HB2434, HB2725, HB2728, HB2729, HB2730, HB2731, HB2732, HB2733

Keywords: nursing board, regulatory actions, disciplinary actions, expungement, healthcare professionalism, controlled substances, prescription monitoring, opioid crisis, healthcare regulations, patient safety, prescription drugs, opioids, healthcare, pain management, utilization controls, AHCCCS, Department of Economic Security, social services, welfare programs, vocational rehabilitation

Summary: The committee first took up several continuation bills to extend state boards and agencies, including HB 2728 for the Department of Economic Security, HB 2729 for the State Board of Nursing, HB 2730 for the Board of Occupational Therapy Examiners, HB 2731 for the Physician Assistants Board, and HB 2732 for the Board of Pharmacy. Each was moved for a due pass recommendation, with HB 2731 amended to continue the physician assistant board for four years instead of two. All of these continuation bills passed the committee with strong support. The committee then heard HB 2408, a nursing board reform bill dealing with complaint investigation procedures, timelines, confidentiality, complaint prioritization, access to investigative files, expungement of certain disciplinary actions, and a revised definition of unprofessional conduct. The sponsor and supporters argued it would improve fairness, allow limited expungement for older non-patient-safety issues, and address long investigation delays. The nursing board president and other opponents warned it would raise the evidentiary standard, weaken patient safety protections, and erase useful disciplinary history. After extensive testimony, the committee adopted an amendment and passed the bill 7-4-1. Next, the committee considered pharmacy-related reforms. HB 2434 updated the controlled substances prescription monitoring program, including registration, reporting, confidentiality, and a compliance work group; it passed unanimously after amendment. HB 2733 allowed pharmacists and technicians to complete continuing education after renewal submission if finished before expiration, clarified prescription delivery locations, and addressed temporary operation during ownership changes; it also passed unanimously after amendment. Finally, HB 2725, which would have restricted access contractors from substituting non-opioid drugs and limiting non-opioid utilization controls, drew concerns that it was too broad and could affect many drug classes and costs. After amendment and debate, the committee failed to give HB 2725 a due pass recommendation by a 6-6 vote, and the meeting adjourned.

Transcript Highlights:

• So what this bill does is create that annual enrollment period that doesn't currently exist for Medigap
• So we are now on the committee substitute for SB 20: Prior Authorization and Prescription Drugs.
• Ensures that patients with serious mental health illnesses have access to prescription medications by
• It does not remove prescription renewal every year.
• You know, you cannot get, in most cases, a long-term prescription.

Bills: SB101, SB21, HM52, HB132, SB14, SB20

Keywords: SB 101, Health Care Delivery and Access Act, repeal of repeal, sunset repeal, delayed repeal, health care, healthcare, access to care, medical services, provider regulation, state health law, New Mexico, SB 21, Medicare supplement, Medigap, open enrollment, guaranteed issue, birthday month enrollment, health insurance, insurance regulation

Transcript Highlights:

• Over five class periods per student for postural screening.
• write a prescription for these under any circumstances.
• , you could make them prescription medicines, and no credible physician would ever write a prescription
• and availability for period products to all menstruators.
• and availability for period products to all menstruators.

Keywords: 995, all

Summary: The Joint Committee on Public Health heard testimony on a wide range of bills focused on environmental health, disease prevention, and access to care. Major topics included restricting polystyrene use, creating a pancreatic cancer awareness and early-detection initiative, improving indoor air quality through a task force and new regulations, expanding access to epinephrine in public places, improving access to health care for people with long COVID, creating an OBGYN loan repayment program for underserved areas, expanding access to hygiene products, modernizing licensure for dietitians and nutritionists, updating school postural screening requirements, and restricting harmful diet pills and muscle-building supplements. Several legislators also testified in support of their own bills, including measures on menstrual product access and ingredient disclosure, and surgical smoke protections. Testimony on the polystyrene bill emphasized local municipal bans and the need to reduce plastic pollution. Pancreatic cancer advocates and patients described the disease’s low survival rate, the difficulty of early diagnosis, and the need for an awareness campaign and implementation of commission recommendations. Indoor air quality supporters from environmental justice groups, public health organizations, and residents described asthma, mold, pollution, and the need for a task force with technical expertise; some witnesses urged adding remediation professionals to the task force. On epinephrine access, family members of a man who died after a bee sting and an allergy organization stressed that anaphylaxis can be sudden and fatal and that stock epinephrine in public venues could save lives. Long COVID advocates said the condition affects hundreds of thousands of residents and called for better surveillance and access to care, with a request to include MECFS in the bills’ scope. Other testimony focused on workforce and equity issues. Supporters of the OBGYN loan repayment bill said it would help address maternal health disparities and provider shortages, especially in rural and underserved communities. Hope and Comfort described widespread hygiene insecurity and a long waiting list for basic products, urging a task force to study statewide solutions. Dietitians and nutritionists supported modernization of licensure to clarify standards for medical nutrition therapy while allowing broader wellness counseling. School nurses backed reducing mandatory postural screenings, arguing the current law is not evidence-based, is not reimbursed by MassHealth, and takes time from other student health needs. On the supplement bill, the industry trade group opposed restrictions as overbroad and burdensome, while a public health expert cited research linking weight-loss and muscle-building supplements to serious harms and urged passage. The committee also heard support for menstrual product access and surgical smoke protections, with legislators and advocates describing those bills as longstanding priorities.

Transcript Highlights:

• The Vermont Prescription Drug Discount Card Program establishes the Vermont Prescription Drug Discount
• > Discount Um, Vermont Prescription Drug Discount Um, Vermont Prescription Drug Discount Card<
• drug cost by pooling reduce prescription drug cost by pooling prescription<00:35:42.200> drug
• <00:36:49.400> drug<00:36:50.440> towards prescription drug towards prescription drug towards
• . periods. periods.

Keywords: 926, house, all

Summary: The House first suspended the rules briefly to make announcements, including welcoming former representative Doug Gage to the gallery. It then returned to House Bill 211 on data brokers and personal information, where the Appropriations Committee explained a $50,000 appropriation to the Secretary of State for a consultant-led study on an accessible deletion mechanism for consumers to delete personal data held by data brokers, with interim and final reports due in 2027 and 2028. The committee reported a 9-0-2 vote in favor, and the House agreed to the Commerce and Economic Development Committee’s amendment and ordered third reading. Floor debate on H. 211 focused heavily on the bill’s deletion and exemption framework. Supporters argued the bill is needed to give Vermonters meaningful control over their data and to prevent data brokers from commingling information for unrelated uses. Opponents warned the bill could conflict with existing federal frameworks such as the Fair Credit Reporting Act, Gramm-Leach-Bliley, and the Driver’s Privacy Protection Act, and could make credit, banking, insurance, fraud prevention, and identity verification harder. In response, the sponsor said the bill uses use-case-based exemptions rather than broad entity-level exemptions, noted testimony from banks, insurers, a data broker, a former data broker employee, and the Attorney General, and said no constitutional concerns were raised. The House ultimately adopted the amendment and advanced the bill. After H. 211, the House moved to House Bill 577, establishing the Vermont Prescription Drug Discount Card Program. Committee reports from Health Care, Ways and Means, and Appropriations were read into the record, and the Colchester member described the bill as a way to lower prescription drug costs by joining the multi-state Array Rx program. The bill would let any Vermont resident obtain a free discount card for FDA-approved prescription drugs, with claimed savings up to 80% on generics and 20% on brand-name drugs. The House then proceeded to second reading on H. 577.

Transcript Highlights:

• Texas is number one for the cost of prescription drug price.
• Their exclusivity period was actually extended to 2032, but in 2023 the exclusivity period...
• Their exclusivity period was actually extended to 2032, but in 2023 the exclusivity period ended 10 years
• Lower-cost prescriptions: that's our fourth tenet of this.
• I tried to get a hold of the local doctor to get her a prescription.

Keywords: 1185, senate, all

Transcript Highlights:

• the 7-day period. the 7-day period.
• And that is, they have to have a prescription.
• <00:19:38.720> that patent on it, make prescriptions that patent on it, make prescriptions
• There's lots of two-year period of time?
• Thank you. ordering the prescriptions and and and ordering the prescriptions and and and actually<01:

Bills: HB2323, HB2324, HB1509, HB2164, HB2165, HB2367, HB2619, HB1765, HB2187, HB1864, HB1452, HB2314, HB1898, HB2558, HB2319, HB1643, HB2121

Keywords: workers' compensation, treatment plans, vocational rehabilitation, electronic submission, reporting requirements, occupational safety, hoisting machines, discrimination protection, Department of Labor, safety standards, treatment plan, injured worker, medical treatment authorization, employer response deadline, secure electronic transmission, facsimile, fax, mail submission, denial of care, medical necessity

Summary: The committee heard several administration bills related largely to workers’ compensation and unemployment insurance. On HB 2323 HD1, which would modernize workers’ compensation notice and filing procedures, DLIR and other agencies testified in support of the original bill language but said HD1 removed key components and weakened the bill’s clarity and continuity. HB 2324 HD1, which would repeal state hoisting-machine certification requirements and the separate crane operator certificate, drew support from DLIR; members asked about whether the change would affect safety or local operators, and DLIR said OSHA-compliant certifications already exist and the union supported the change. HB 1509 HD1, which would require faster employer responses to treatment plans and impose penalties for nonresponse, received support from DLIR and others, while DHRD said it wanted an amendment. The committee also took up HB 2164 HD1 on compounded prescription drugs in workers’ compensation. DLIR supported the bill as a way to define compounded drugs and curb inflated pricing, but DHRD and a medical provider opposed it and asked for amendments. Testimony focused heavily on whether the definition should include 503B compounding facilities and whether physician dispensing should be limited to the first 30 days after injury. HB 2165 HD1, dealing with unemployment insurance eligibility and removing the two-year limit on recouping overpayments, was supported by DLIR but opposed by Unite Here Local 5, which argued it would make it harder for striking workers and other claimants. Members questioned the impact of changing reporting deadlines from calendar days to business days and raised concerns about future benefit offsets; DLIR said the bill was needed for federal conformity and that the committee would revisit the offset percentage and effective date. Later, the committee heard HB 2367 on pay transparency, requiring salary ranges in job postings and removing the small-employer exemption. The Hawaii Civil Rights Commission, AAUW, Hawaii Women Lawyers, and an individual testifier supported the bill, saying pay transparency promotes fairness, trust, and pay equity; one testifier described being underpaid compared with a predecessor and said posting ranges would save applicants’ time. HB 2619 HD1, concerning homemade food products and farm kitchens, received generally supportive comments from the Department of Health, which requested an amendment to preserve flexibility in future rulemaking. HB 1765 HD1, on spear-fishing safety warnings, drew support from a safety educator and comments from DLNR; supporters said warning labels would help prevent hypoxic blackout deaths and were low-cost and easy to implement. No votes or final committee actions were taken in the portion of the meeting provided.

Transcript Highlights:

• Period of time. Yeah. Yes.
• definition because it says for a period definition because it says for a period of<01:36:49.440>
• <01:37:10.480> of felt sad or hopeless for a period of felt sad or hopeless for a period of
• We're seeing an increase prescriptions.
• <02:08:08.320> for 50 in one county has a prescription for 50 in one county has a prescription

Keywords: 928, house, all

Summary: The committee met with DHS Chief Financial Officer Nathan White to receive an update on the department’s budget lapse and vacancy rates. White explained the difference between the “back-of-the-budget” reduction and lapse assumptions, saying DHS is facing a current biennium reduction of about $23 million and estimating roughly a $60 million general fund lapse in state fiscal year 2025, compared with about $13.5 million the prior year. He said DHS’s lapse is driven largely by program utilization, labor market conditions, contract spending, and statutory carry-forwards in areas such as Medicaid and developmental disabilities, which tend to produce a smaller lapse in the first year of the biennium and a larger one in the second year. He also noted that the House and Senate budgets differ on some operating items, including Medicaid rates, with the Senate having struck a House proposal to reduce rates by 3%. Members questioned White about whether DHS ever spends down lapse money on last-minute purchases. He said the department does not engage in that practice, though it does retain some flexibility in its facilities budget for emergencies. He also described the process for transferring funds within and between class lines, including the need for fiscal committee approval above statutory thresholds, and gave examples such as moving funds to cover overtime in the SYSC budget and to ensure Medicaid payments for nursing facilities. White said such transfers are public and transparent and are reviewed by the governor and Executive Council. The committee then discussed DHS staffing. White said the department has a little over 3,200 authorized positions, with a vacancy rate around 14.5%, and that a hiring freeze had been imposed a few months earlier while exempting direct care positions. He said DHS is planning for about a $30 million general fund reduction to personnel, equivalent to just under 400 positions, and is managing postings centrally to stay within budget by July 1. In response to questions about the loss of about $80 million in federal funds, White and Associate Commissioner Patricia Tilly said DHS avoided layoffs by shifting staff into vacant positions, but that the cuts affected community contracts, public health workers, laboratory work, and some IT/data projects. Tilly said roughly 20 positions were affected, most were reassigned, a few staff left voluntarily, and the department has less flexibility going forward if more federal funding ends.

Transcript Highlights:

• <00:03:30.440> drug managed the Medicaid prescription drug managed the Medicaid prescription
• <00:05:14.640> that also, uh, dispense prescriptions that also, uh, dispense prescriptions
• So that is which prescriptions apply.
• You cannot take a discount on more than one discount on the same prescription at the prescription level
• it was not a 340B prescription. it was not a 340B prescription.

Keywords: 1187, senate, all

Transcript Highlights:

• And then on page 14, the prescription is written for drugs that may have a cosmetic use.
• It could change incrementally over that period of time. Am I correct with that? Dr.
• Now, if there's a change in the prescription, the clinician... Dr.
• Now, if there's a change in the prescription, the clinician is going to do that.
• Ryan: The majority of prescriptions have a legal limit of 12 months.

Bills: SB20, SB111, SB211, SB218, SB14

Keywords: prior authorization, pharmacy benefits manager, PBM, health insurer, prescription drugs, step therapy, formulary, auto-adjudication, electronic portal, appeals, medical necessity, serious mental illness, mental health, schizophrenia, bipolar disorder, major depression, substance use disorder, addiction treatment, cancer, autoimmune disorder

Transcript Highlights:

• But what you are describing, where you place someone on probation for a period of time to monitor them
• So we did a 45-day comment period where people had the opportunity. We did a regulation hearing.
• Once the board votes to make additional changes, additional comment periods are opened up.
• And so it's generally through the comment periods where people are welcome to submit comments.
• Patients also fill prescriptions at more than one pharmacy.

Summary: The joint Assembly and Senate business committees held a sunset review hearing on the California State Board of Pharmacy, with board leadership describing the board’s consumer-protection role and its priorities around access, enforcement, and updating pharmacy law. The board emphasized a proposed shift toward a standard-of-care model for pharmacists, arguing it would reduce rigid protocol requirements and improve access to services such as HIV PrEP/PEP, contraception, and naloxone. Board representatives also discussed pharmacy deserts, possible fee waivers for pharmacies in underserved areas, concerns about payer practices contributing to closures, continuing education audits, and a request to restore more flexibility in licensure decisions and probationary monitoring for applicants with certain criminal histories. A major focus of the hearing was the board’s ongoing compounding regulations, especially the treatment of sterile versus nonsterile compounding and substances such as glutathione and methylcobalamin. The board said the proposal was not a ban on those substances and described the rulemaking as grounded in federal law, USP standards, and public comment, noting the process had gone through multiple modified texts and hearings. Testimony from stakeholders was sharply divided: pharmacists, veterinarians, firefighters, naturopathic doctors, and patient advocates warned the rules were restricting access to compounded medications and harming patients and first responders, while the California Medical Association, psychiatric physicians, and PhRMA raised concerns that the board’s proposals could expand pharmacist authority beyond training, affect physician practice, or create safety risks. Other public comments addressed pharmacy technician ratios, remote processing, flavoring medications, hospital-specific regulation, budget and enforcement transparency, and whether the board should add members with community compounding or pharmacy technician expertise. Committee members also asked about the board’s oversight priorities and the rationale for its standard-of-care proposal. Board staff explained that consumer protection includes education, licensing, policy, and enforcement, with the highest-priority enforcement cases being those posing imminent public harm. After public testimony concluded, the chairs thanked participants and adjourned the sunset review hearing, announcing an immediate transition to the joint informational hearing on the Department of Cannabis Control.

Transcript Highlights:

• The original law was passed in 2017, and while there have been periodic updates to it for the past several
• This reporting platform is actually similar to what the FDA does for prescription medications.
• And we are following them throughout that time period where they had an active certification.
• Everything that I’m doing is focusing on the safety of prescription medications.
• I mean, every prescription medication that is on the market has benefit and risk.

Summary: The Health Professions and Program Subcommittee met to receive oversight briefings on Florida’s medical marijuana program from the Department of Health’s Office of Medical Marijuana Use (OMMU) and from the University of Florida’s Consortium for Medical Marijuana Clinical Outcomes Research. OMMU Director Christopher Kimball outlined the program’s structure, including more than 900,000 active patients, nearly 7,000 caregivers, 27 MMTC licensees, 706 dispensing locations, and nine certified testing labs. He described the state’s pre-approval process for products and advertising, plain packaging requirements, seed-to-sale tracking, registry operations, and compliance efforts such as background checks, inspections, complaint investigations, and lab desk audits. He also said the Bureau of Public Health Laboratories in Jacksonville had been accredited to begin supporting testing. Members asked about telehealth, patient growth, product safety, advertising to children, inspections, and the status of MMTC licensure; Kimball said recertifications by telehealth now make up more than half of recertifications, that patient growth has slowed, and that ongoing litigation is delaying issuance of 22 new MMTC licenses. Kimball also discussed implementation of recent legislation and licensure changes, including licenses issued under HB 387 and SB 1582 to applicants from the original Pigford-related pool, with additional cure opportunities still ongoing. He said the department is monitoring diversion, inversion, and unapproved products, and that it coordinates with law enforcement when needed but does not itself have sworn authority. In response to questions, he said the department does not regulate physicians directly, but may refer concerns to the Division of Medical Quality Assurance, and that caregiver and physician participation requirements are set by statute. Members raised concerns about edibles, child access, and continued use of child-attractive branding; Kimball said the department tries to catch issues through pre-approval and enforcement, and that complaints involving children are treated as serious and investigated using available records and camera footage. Dr. Almond Winterstein then presented the consortium’s research overview. He explained that the consortium was created by statute in 2019, includes 10 universities, and is funded by annual state appropriations. He said its work includes grants, a research repository, a clinical core, outreach, and evidence synthesis, including a recent FDA-supported review of cannabis evidence. He emphasized that the current evidence base is limited and often low quality, with the strongest signals for symptom relief in PTSD-related symptoms, nausea, and some pain outcomes, but with many studies inconclusive or mixed. He also described the consortium’s use of registry data linked to Medicaid, Medicare, death, fetal death, and birth records to study safety and outcomes, including children, pregnancy, driving safety, opioid-sparing effects, and adverse events. Winterstein said adverse event reporting is sparse and likely underreported, with most reports mild but some serious events noted, and he expressed concern about use among young adults because of uncertain benefit-risk and possible effects on the developing brain. The committee discussed the need for better surveillance, more robust adverse event reporting, and the possibility of using linked data to identify harms more quickly. At the end of the meeting, the committee rose without objection.

Transcript Highlights:

• trusts and this bill sets a time period trusts and this bill sets a time period that<00:18:18.360
• Patty Southerland suffered a traumatic brain injury from a fall, and she was given a prescription for
• It took Patty six months to get an appointment with her neurologist to get an updated prescription.
• <00:33:58.000> that when she provided the prescription that when she provided the prescription
• > longer<00:34:00.159> valid that prescription was no longer valid that prescription was

Keywords: 1187, senate, all

Transcript Highlights:

• For example, prescriptions.
• That's the problem. fill that prescription. Uh follow-up fill that prescription.
• <01:49:14.080> I prescription costs to go up? Sure. I prescription costs to go up? Sure.
• prescription costs go up? prescription costs go up?
• critical in a period of volatility. critical in a period of volatility.

Keywords: 928, house, all

Summary: The committee first heard Senate Bill 47, sponsored by Sen. Regina Birdsell at the request of the Insurance Department. The bill would codify the department’s interpretation that a birth mother’s health insurance is the primary coverage for a newborn, unless the mother has no insurance or coverage under an employer-sponsored plan. Birdsell and Insurance Commissioner DJ Benton Court said the measure is a clarification of existing practice and intended to protect vulnerable newborns; a question from Rep. Miles clarified that if a young woman is on her parents’ policy, the newborn would generally be covered under that family coverage. The hearing on SB 47 was then closed. The committee then took up Senate Bill 121, introduced by Grant Bosi for Sen. Kevin Avard, which would require insurers to notify the Insurance Department when they stop writing an entire line of business or, in some cases, Medicare Advantage plans. Commissioner Benton Court said the bill arose from disruption in the Medicare Advantage market, where consumers, brokers, and the department were confused by carriers changing or ending offerings; he said the department wanted a simple notification requirement so it could better advise consumers. Members discussed network adequacy, county-based service areas, and the fact that the bill would make notice a condition of licensure, with possible fines or license action for noncompliance. Witness Paula Rogers of AHIP said her group supported the bill if amended, and the department indicated it would support a change from a 120-day notice period to 90 days to align with state rules; the committee planned to work on an amendment in subcommittee. Finally, the committee heard Senate Bill 247, introduced by Rep. Brian Cole, which would prohibit network exclusion of pharmacies that refuse to dispense prescriptions when PBM reimbursement is below acquisition cost. Cole argued the bill is meant to stop pharmacies from being forced to sell drugs at a loss, describing PBMs as middlemen and saying the measure is a compromise that protects local pharmacies. Members questioned whether consumers would pay more and whether pharmacies voluntarily enter PBM contracts; Cole responded that the bill would let pharmacies refuse unprofitable fills while consumers could still obtain the drug through mail order or other channels. He also said the issue has changed over time because the practice now affects a much larger share of generics and is concentrated among a few PBMs. The hearing remained open as questions continued, with no vote taken in the excerpt.